AIScriptReader 每月有 3,276 次造訪，月增率 +8%，定價模式為付費。Command Code 每月有 2,358,177 次造訪，成長率 -12.1%，定價模式為免費增值、需聯絡報價。
會學習你編碼品味的 AI 編程代理
| 面向／指標 |  | |
|---|---|---|
| 官方網域 | aiscriptreader.com | commandcode.ai |
| 定價模式 | 付費 | 免費增值、需聯絡報價 |
| 每月造訪次數 | 3276 (3,276) | 235.82萬 (2,358,177) |
| 月流量變化量 | +242 (+8%) | -32.57萬 (-12.1%) |
| 主要市場與市佔 | 🇺🇸 美國 (97.4%) | 🇨🇳 中國 (47%) |
| 每月直接造訪 | 1294 | 174.96萬 |
| 使用者評分 | 3.8 | 4.3 |
| 支援平台 | 網站 | 網站 |
即時 AI 劇本分析與開發意見
在一份文件中結構化呈現一句話故事、劇情梗概、人物分析、主題、結構與市場潛力。
細緻到具體場景與版本的優劣標註與修改建議。
就人物、情節與主題繼續提問，獲得針對你劇本的個人化建議。
上傳多部劇本，將所有審讀紀錄、報告與意見集中在一處管理。
會學習你編碼品味的 AI 編程代理
持續強化學習層把每一次採納、拒絕與手動編輯變成訊號，再把反覆出現的模式轉化為可重複使用的專案層級技能。
自動修復格式錯誤的工具呼叫，讓較弱的開放權重模型也能可靠完成代理循環，接近前沿模型的水準。
互動式 CLI 用於結對，無頭旗標用於腳本化，背景沙箱代理則用於更長時間的自主任務。
自訂 /agents 與持久化 /memory 跨工作階段攜帶專案上下文，讓你不必反覆解釋程式庫與規範。
專項更強Offers industry-leading reasoning and artifact generation, but lacks direct terminal-first integration and local preference memory.
免費 / 開源Orchestrates multiple CLI coding agents in parallel git worktrees, but is less focused on single-user preference learning.
免費 / 開源Type.ai is an AI writing assistant and full document editor for long-form creative writing, built for authors, novelists and screenwriters who need to draft and revise book-length work in one place.
免費 / 開源Type.ai is an AI writing assistant and full document editor for long-form creative writing, built for authors, novelists and screenwriters who need to draft and revise book-length work in one place.
免費 / 開源Paper Digest is an AI research platform that summarizes literature, generates literature reviews with citations, and delivers daily digests of new papers across arXiv, PubMed, bioRxiv and major conferences. Launched in 2018 and used by millions of researchers, it combines a citation-backed review engine that avoids inventing results with tools for reading PDFs, writing, question answering, claim verification and topic tracking.
免費 / 開源Paper Digest is an AI research platform that summarizes literature, generates literature reviews with citations, and delivers daily digests of new papers across arXiv, PubMed, bioRxiv and major conferences. Launched in 2018 and used by millions of researchers, it combines a citation-backed review engine that avoids inventing results with tools for reading PDFs, writing, question answering, claim verification and topic tracking.
